Total Payments
$28,888
2023 Payments
$124.85
Companies
14
Transactions
68
Payment Breakdown by Category
Consulting$18,013 (62.4%)
Other$5,678 (19.7%)
Food & Beverage$2,213 (7.7%)
Travel$1,941 (6.7%)
Research$946.02 (3.3%)
Education$96.81 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,013 | 6 | 62.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,528 | 8 | 19.1% |
| Food and Beverage | $2,213 | 34 | 7.7% |
| Travel and Lodging | $1,941 | 8 | 6.7% |
| Unspecified | $946.02 | 8 | 3.3% |
| Honoraria | $150.00 | 1 | 0.5% |
| Education | $96.81 | 3 | 0.3% |
Payments by Type
General
$27,942
60 transactions
Research
$946.02
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $8,308 | 10 | $0 (2021) |
| Shire North American Group Inc | $7,749 | 12 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $4,108 | 13 | $0 (2017) |
| Novo Nordisk Inc | $3,923 | 6 | $0 (2020) |
| Genentech, Inc. | $2,200 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $1,262 | 9 | $0 (2019) |
| Spark Therapeutics, Inc. | $448.51 | 6 | $0 (2023) |
| Grifols Shared Services North America, Inc. | $263.52 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $236.92 | 2 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $150.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $124.85 | 1 | Spark Therapeutics, Inc. ($124.85) |
| 2022 | $151.45 | 3 | AstraZeneca Pharmaceuticals LP ($99.57) |
| 2021 | $5,617 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($3,335) |
| 2020 | $5,184 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($4,973) |
| 2019 | $1,798 | 15 | Daiichi Sankyo Inc. ($1,262) |
| 2018 | $11,811 | 19 | Shire North American Group Inc ($7,615) |
| 2017 | $4,202 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($4,108) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2023 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.85 | General |
| 09/15/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $99.57 | General |
| Category: Rare Disease | ||||||
| 07/10/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.86 | General |
| 04/06/2022 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $32.02 | General |
| 11/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Consulting Fee | Cash or cash equivalent | $1,610.00 | General |
| Category: HEMATOLOGY | ||||||
| 08/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| 07/01/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| 06/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| 06/27/2021 | Genentech USA, Inc. | HEMLIBRA (Biological) | Food and Beverage | In-kind items and services | $81.62 | General |
| Category: Hematology | ||||||
| 05/06/2021 | Genentech, Inc. | HEMLIBRA (Biological) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: Hematology | ||||||
| 11/18/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,170.00 | General |
| 11/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: HEMATOLOGY | ||||||
| 09/02/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADYNOVATE (Biological) | Consulting Fee | Cash or cash equivalent | $1,170.00 | General |
| Category: HEMATOLOGY | ||||||
| 08/25/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $780.00 | General |
| Category: HEMATOLOGY | ||||||
| 07/28/2020 | Novo Nordisk Inc | Esperoct (Biological) | Education | In-kind items and services | $32.27 | General |
| Category: Hemophilia | ||||||
| 07/28/2020 | Novo Nordisk Inc | Esperoct (Biological) | Education | In-kind items and services | $32.27 | General |
| Category: Hemophilia | ||||||
| 07/28/2020 | Novo Nordisk Inc | Esperoct (Biological) | Education | In-kind items and services | $32.27 | General |
| Category: Hemophilia | ||||||
| 07/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $682.50 | General |
| Category: HEMATOLOGY | ||||||
| 07/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $195.00 | General |
| Category: HEMATOLOGY | ||||||
| 02/25/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $115.02 | General |
| Category: HEMATOLOGY | ||||||
| 12/19/2019 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $119.85 | General |
| 12/08/2019 | Grifols Shared Services North America, Inc. | Thrombate III (Biological) | Food and Beverage | In-kind items and services | $88.60 | General |
| Category: Hematology | ||||||
| 06/27/2019 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 05/01/2019 | Amgen Inc. | Nplate (Biological) | Food and Beverage | In-kind items and services | $37.49 | General |
| Category: Hematology | ||||||
| 04/13/2019 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $99.92 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric | Bayer HealthCare Pharmaceuticals Inc. | $946.02 | 8 |
About Gavin Roach
Gavin Roach is a Pediatric Hematology-Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1669634218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gavin Roach has received a total of $28,888 in payments from pharmaceutical and medical device companies, with $124.85 received in 2023. These payments were reported across 68 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($18,013).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Los Angeles, CA
- Active Since 06/25/2008
- Last Updated 12/09/2020
- Taxonomy Code 2080P0207X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669634218
Products in Payments
- ADVATE (Biological) $4,243
- NovoSeven RT (Drug) $3,826
- Non-Covered $3,162
- HEMLIBRA (Biological) $2,282
- ADYNOVATE (Biological) $1,264
- Savaysa (Drug) $1,262
- Xarelto (Drug) $946.02
- Alphanate (Biological) $195.99
- Soliris (Drug) $150.00
- ADAKVEO (Biological) $115.02
- ANDEXXA (Biological) $99.57
- Esperoct (Biological) $96.81
- Thrombate III (Biological) $88.60
- Nplate (Biological) $37.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Los Angeles
Jan Van Tornout, Md, MD
Pediatric Hematology-Oncology — Payments: $470,897
Pediatric Hematology-Oncology $470,897
Noah Federman, M.d, M.D
Pediatric Hematology-Oncology — Payments: $353,544
Pediatric Hematology-Oncology $353,544
Thomas Coates, Md, MD
Pediatric Hematology-Oncology — Payments: $158,777
Pediatric Hematology-Oncology $158,777
Dr. Andrew Dietz, Md, Ms, MD, MS
Pediatric Hematology-Oncology — Payments: $88,475
Pediatric Hematology-Oncology $88,475
Mr. Paul Gaynon, M.d, M.D
Pediatric Hematology-Oncology — Payments: $65,183
Pediatric Hematology-Oncology $65,183
Edward Gomperts, Md, MD
Pediatric Hematology-Oncology — Payments: $65,090
Pediatric Hematology-Oncology $65,090